Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Compound trial record
Compound · clinical trials

Norditropin clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — the 6 trials in our China, France, Ireland, UK, USA, India, Spain, Italy, Poland, Switzerland, Austria, Canada, Japan, Israel, Germany, Netherlands, Belgium, Portugal, Brazil, Mexico, South Korea, Denmark and Norway registers that name Norditropin as an intervention. Synced 8 Nov 2026
6Current trials
1Recruiting now
2Lead sponsors
23Country registers
At a glance

Norditropin is named as an intervention in 6 current clinical trials in our China, France, Ireland, UK, USA, India, Spain, Italy, Poland, Switzerland, Austria, Canada, Japan, Israel, Germany, Netherlands, Belgium, Portugal, Brazil, Mexico, South Korea, Denmark and Norway registers. 1 is recruiting patients now. The most common phase is Phase 1/2. The sponsor with the most trials is Novo Nordisk A/S (3). The most-studied condition is SGA, Turner Syndrome, Noonan Syndrome, ISS.

Patient leaflets for Norditropin

The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.

  • UK
    United Kingdom: Search MHRA Products
    Patient information leaflets and SmPCs for UK-licensed products.
  • US
    United States: Search DailyMed
    FDA-approved labels, including patient and medication guides.

Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.

Trials by status

  • Recruiting117%
  • Not yet open233%
  • Active, closed233%
  • By invitation117%

Trials by phase

  • Phase 1/2233%
  • Phase 3117%
  • Phase 2117%
  • Phase 1117%
  • Observational117%
01

Clinical trials of Norditropin

6 trials
StudyPhaseStatusLead sponsorRegisters
A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
NCT07016802 · ClinicalTrials.gov ↗ · Safety, Tolerability, Adult Growth Hormone Deficiency
Phase 1 Recruiting Changchun GeneScience Pharmaceutical Co., Ltd China
A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)
NCT07450001 · ClinicalTrials.gov ↗ · Pediatric Growth Hormone Deficiency
Phase 1/2 Not yet open Changchun GeneScience Pharmaceutical Co., Ltd China
A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)
NCT07450053 · ClinicalTrials.gov ↗ · Idiopathic Short Stature
Phase 1/2 Not yet open Changchun GeneScience Pharmaceutical Co., Ltd China
French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome
NCT05308927 · ClinicalTrials.gov ↗ · Noonan Syndrome
Observational By invitation Novo Nordisk A/S France
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
NCT05330325 · SGA, Turner Syndrome, Noonan Syndrome, ISS
Phase 3 Active, closed Novo Nordisk A/S Ireland, UK, USA, India, China, Germany, France, Spain, Italy, Netherlands, Belgium, Poland, Switzerland, Austria, Portugal, Canada, Brazil, Mexico, Japan, South Korea, Israel
A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day
NCT03878446 · Short Stature Children Born Small for Gestational Age (SGA)
Phase 2 Active, closed Novo Nordisk A/S Ireland, UK, USA, India, France, Spain, Italy, Denmark, Poland, Switzerland, Austria, Norway, Canada, Japan, Israel

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.

02

Conditions studied with Norditropin

8 conditions
SGA, Turner Syndrome, Noonan Syndrome, ISS1Short Stature Children Born Small for Gestational Age (SGA)1Safety1Tolerability1Adult Growth Hormone Deficiency1Pediatric Growth Hormone Deficiency1Idiopathic Short Stature1Noonan Syndrome1
05

Related compounds

06

Questions about Norditropin trials

How many clinical trials are testing Norditropin?

6 current trials in our China, France, Ireland, UK, USA, India, Spain, Italy, Poland, Switzerland, Austria, Canada, Japan, Israel, Germany, Netherlands, Belgium, Portugal, Brazil, Mexico, South Korea, Denmark and Norway registers name Norditropin as a drug or biological intervention, as of the registry sync on 8 November 2026. Completed and withdrawn studies are not counted.

Are Norditropin trials recruiting patients?

Yes. 1 of the 6 trials is recruiting: 1 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Who sponsors Norditropin clinical trials?

Novo Nordisk A/S (3) and Changchun GeneScience Pharmaceutical Co., Ltd (3). The number in brackets is how many trials each organisation leads.

Are there Norditropin clinical trials in Ireland?

Yes. 2 trials in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Norditropin works or whether it is effective, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Norditropin works or whether it is effective. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Norditropin (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 8 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.